AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases. [electronic resource]
Producer: 20120622Description: 2170-80 p. digitalISSN:- 1552-5783
- Angiogenesis Inhibitors -- pharmacokinetics
- Angiopoietin-1 -- antagonists & inhibitors
- Angiopoietin-2 -- antagonists & inhibitors
- Animals
- Animals, Newborn
- Autoradiography
- Capillary Permeability -- drug effects
- Choroidal Neovascularization -- metabolism
- Disease Models, Animal
- Eye -- metabolism
- Female
- Fluorescein Angiography
- Humans
- In Situ Hybridization
- Infant, Newborn
- Macaca fascicularis
- Male
- Mice
- Mice, Inbred C57BL
- Recombinant Fusion Proteins -- pharmacokinetics
- Retinal Neovascularization -- metabolism
- Retinal Vessels -- drug effects
- Retinopathy of Prematurity -- metabolism
- Tissue Distribution
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.